These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity. Elad-Sfadia G; Haklai R; Balan E; Kloog Y J Biol Chem; 2004 Aug; 279(33):34922-30. PubMed ID: 15205467 [TBL] [Abstract][Full Text] [Related]
3. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells. Ulkü AS; Schäfer R; Der CJ Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291 [TBL] [Abstract][Full Text] [Related]
4. Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cells. Shalom-Feuerstein R; Cooks T; Raz A; Kloog Y Cancer Res; 2005 Aug; 65(16):7292-300. PubMed ID: 16103080 [TBL] [Abstract][Full Text] [Related]
5. Single-molecule diffusion measurements of H-Ras at the plasma membrane of live cells reveal microdomain localization upon activation. Lommerse PH; Snaar-Jagalska BE; Spaink HP; Schmidt T J Cell Sci; 2005 May; 118(Pt 9):1799-809. PubMed ID: 15860728 [TBL] [Abstract][Full Text] [Related]
6. Analysis of Ras-induced oncogenic transformation of NIH-3T3 cells using differential-display 2-DE proteomics. Ji H; Moritz RL; Kim YS; Zhu HJ; Simpson RJ Electrophoresis; 2007 Jun; 28(12):1997-2008. PubMed ID: 17526045 [TBL] [Abstract][Full Text] [Related]
7. Membrane interactions of a constitutively active GFP-Ki-Ras 4B and their role in signaling. Evidence from lateral mobility studies. Niv H; Gutman O; Henis YI; Kloog Y J Biol Chem; 1999 Jan; 274(3):1606-13. PubMed ID: 9880539 [TBL] [Abstract][Full Text] [Related]
8. The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer. Rotblat B; Ehrlich M; Haklai R; Kloog Y Methods Enzymol; 2008; 439():467-89. PubMed ID: 18374183 [TBL] [Abstract][Full Text] [Related]
9. Transformation but not ras-transfection increases the expression of galectin-3 in human HOS cells. Hébert E; Roche AC; Nachtigal M; Monsigny M C R Acad Sci III; 1996 Oct; 319(10):871-7. PubMed ID: 8977767 [TBL] [Abstract][Full Text] [Related]
10. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways. Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477 [TBL] [Abstract][Full Text] [Related]
11. A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblasts. Bossù P; Vanoni M; Wanke V; Cesaroni MP; Tropea F; Melillo G; Asti C; Porzio S; Ruggiero P; Di Cioccio V; Maurizi G; Ciabini A; Alberghina L Oncogene; 2000 Apr; 19(17):2147-54. PubMed ID: 10815806 [TBL] [Abstract][Full Text] [Related]
13. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta. Du J; Jiang B; Coffey RJ; Barnard J Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945 [TBL] [Abstract][Full Text] [Related]
14. Direct visualization of Ras proteins in spatially distinct cell surface microdomains. Prior IA; Muncke C; Parton RG; Hancock JF J Cell Biol; 2003 Jan; 160(2):165-70. PubMed ID: 12527752 [TBL] [Abstract][Full Text] [Related]
15. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Hanafusa H; Torii S; Yasunaga T; Nishida E Nat Cell Biol; 2002 Nov; 4(11):850-8. PubMed ID: 12402043 [TBL] [Abstract][Full Text] [Related]
16. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1. Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690 [TBL] [Abstract][Full Text] [Related]